Compare ALEMBIC PHARMA with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PFIZER ALEMBIC PHARMA/
PFIZER
 
P/E (TTM) x 15.3 36.5 41.8% View Chart
P/BV x 3.8 6.2 61.5% View Chart
Dividend Yield % 1.0 0.6 181.3%  

Financials

 ALEMBIC PHARMA   PFIZER
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
PFIZER
Mar-19
ALEMBIC PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs6643,840 17.3%   
Low Rs4122,080 19.8%   
Sales per share (Unadj.) Rs208.7455.0 45.9%  
Earnings per share (Unadj.) Rs31.093.8 33.1%  
Cash flow per share (Unadj.) Rs37.1109.4 33.9%  
Dividends per share (Unadj.) Rs5.5022.50 24.4%  
Dividend yield (eoy) %1.00.8 134.4%  
Book value per share (Unadj.) Rs144.2658.2 21.9%  
Shares outstanding (eoy) m188.5245.75 412.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.66.5 39.6%   
Avg P/E ratio x17.431.6 55.0%  
P/CF ratio (eoy) x14.527.1 53.6%  
Price / Book Value ratio x3.74.5 83.0%  
Dividend payout %17.724.0 74.0%   
Avg Mkt Cap Rs m101,461135,420 74.9%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m7,4673,238 230.6%   
Avg. sales/employee Rs ThNM7,911.4-  
Avg. wages/employee Rs ThNM1,230.9-  
Avg. net profit/employee Rs ThNM1,630.7-  
INCOME DATA
Net Sales Rs m39,34720,815 189.0%  
Other income Rs m941,674 5.6%   
Total revenues Rs m39,44122,489 175.4%   
Gross profit Rs m8,7365,712 152.9%  
Depreciation Rs m1,152714 161.4%   
Interest Rs m18473 252.5%   
Profit before tax Rs m7,4936,599 113.5%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5682,309 67.9%   
Profit after tax Rs m5,8444,291 136.2%  
Gross profit margin %22.227.4 80.9%  
Effective tax rate %20.935.0 59.8%   
Net profit margin %14.920.6 72.1%  
BALANCE SHEET DATA
Current assets Rs m19,57727,167 72.1%   
Current liabilities Rs m14,8968,917 167.1%   
Net working cap to sales %11.987.7 13.6%  
Current ratio x1.33.0 43.1%  
Inventory Days Days9068 132.3%  
Debtors Days Days4530 150.7%  
Net fixed assets Rs m27,0978,862 305.8%   
Share capital Rs m377458 82.4%   
"Free" reserves Rs m26,81129,656 90.4%   
Net worth Rs m27,18830,113 90.3%   
Long term debt Rs m4,99325 19,972.0%   
Total assets Rs m47,77839,400 121.3%  
Interest coverage x41.791.5 45.6%   
Debt to equity ratio x0.20 22,120.8%  
Sales to assets ratio x0.80.5 155.9%   
Return on assets %12.611.1 113.9%  
Return on equity %21.514.2 150.9%  
Return on capital %23.622.1 106.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,453428 4,541.8%   
Fx outflow Rs m6,065786 771.2%   
Net fx Rs m13,388-358 -3,738.6%   
CASH FLOW
From Operations Rs m8,120978 830.1%  
From Investments Rs m-7,556351 -2,151.5%  
From Financial Activity Rs m590-1,099 -53.7%  
Net Cashflow Rs m1,153231 499.7%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 2.9 7.5 38.7%  
FIIs % 9.1 4.9 185.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 23.7 58.6%  
Shareholders   49,328 85,207 57.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Nov 18, 2019 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - GSK PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS